This week, drugmakers had a scare when President Trump threatened to levy tariffs of up to 250% on imported pharmaceuticals.

Palantir Technologies • PLTR-Nasdaq Hold • $160.66 on Aug. 4 by Deutsche Bank Palantir delivered another impressive result, ...

Flush with Trump connections, Ballard Partners is D.C.’s new lobbying powerhouse — and its clients are reaping the benefits.